Transfusional Iron Overload (2)

Transfusional Hemosiderosis (1)

Completed (2)

phase 2 (1)

ApoPharma (1)

Novartis Pharmaceuticals (1)

core study: deferasirox (1)

core study: deferoxamine (1)

deferasirox (1)

deferoxamine (1)

extension: deferasirox to deferoxamine (1)

extension: deferoxamine to deferasirox (1)

drug (1)

Industry (2)

Interventional (1)

Observational (1)

Transfusional Iron Overload

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS